[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361930-105":59,"doc-detail-361930-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","actinic-keratosis-comprehensive-review-of-current-treatments-and-emerging-therapeutic-innovations","Actinic keratosis - comprehensive review of current treatments and emerging therapeutic innovations","","Actinic keratosis (AK) is a common benign intraepidermal dysplasia that is classified as squamous cell carcinoma in situ (SCC in situ). Chronic ultraviolet exposure is the primary etiological factor, and lesions typically appear on sun-exposed areas. Management prioritizes primary prevention via patient education, sun protection, and vigilant monitoring. Treatment strategies are organized into lesion-directed and field-directed approaches, including topical agents and physical modalities. This review summarizes current therapies and evaluates emerging therapeutic options.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/actinic-keratosis-comprehensive-review-of-current-treatments-and-emerging-therapeutic-innovations/361930/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/actinic-keratosis-comprehensive-review-of-current-treatments-and-emerging-therapeutic-innovations/361930.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is actinic keratosis and why is it clinically important?","Question",{"text":113,"@type":114},"Actinic keratosis (AK) is a prevalent benign intraepidermal dysplasia, classified as squamous cell carcinoma in situ (SCC in situ). Because it is a precancerous condition, early treatment and prevention are important to reduce progression to invasive cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What causes actinic keratosis and where does it typically occur?",{"text":118,"@type":114},"Chronic ultraviolet (UV) light exposure is the primary etiological factor. AK mainly develops on chronically sun-exposed body areas such as the face, scalp, neck, and the dorsum of the hands.",{"name":120,"@type":111,"acceptedAnswer":121},"How are AK treatment strategies classified?",{"text":122,"@type":114},"AK treatment is categorized as lesion-directed or field-directed. Lesion-directed therapy targets individual lesions, while field-directed therapy addresses multiple widespread and subclinical lesions within field cancerization.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},361930,1790194440,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Review paper  \nActinic keratosis: comprehensive review of current treatments and emerging therapeutic innovations  \nJustyna Ceryn, Aleksandra Lesiak, Dorota Sobolewska-Sztychny, Marcin Noweta, Magdalena Ciążyńska, Joanna Narbutt  \nDepartment of Dermatology, Paediatric Dermatology and Oncology Clinic, Medical University of Lodz, Poland  \nAdv Dermatol Allergol 2025; XLII (3): 221–231 DOI: [https://doi.org/10.5114/ada.2024.147331](https://doi.org/10.5114/ada.2024.147331)  \nAbstract  \nActinic keratosis (AK) is a prevalent benign intraepidermal dysplasia, classified as squamous cell carcinoma in situ (SCC in situ) . Chronic ultraviolet (UV) light exposure is the primary etiological factor for AK, which predominantly manifests in sun-exposed areas. Management of AK emphasizes primary prevention through education, sun protection, and vigilant patient monitoring. Therapeutic strategies for AK are categorized into lesion-directed and field-directed approaches, encompassing topical treatments (imiquimod, 5-fluorouracil, diclofenac) and physical modalities (cryotherapy, photodynamic therapy, chemical peels, laser therapy, electrocoagulation, curettage) . This comprehensive review discusses the current treatments and explores novel therapeutic options for AK.  \nKey words: actinic keratosis, systematic review, treatment.  \nIntroduction  \nActinic keratosis (AK) is one of the most common dermatological diseases. It is a benign intraepidermal proliferation that is a precancerous condition known assquamous cell carcinoma in situ (SCC in situ) . It affects around 25% of the adult population, especially elderly people with a prevalence of 4.6% and 14.57% in the age group of 60–69 years and in those older than 80 years, respectively [1, 2] . Clinically, AKs are characterized by the presence of hyperkeratosis and erythema. The main triggering factor of AK is chronic UV-light exposure, thus, it is commonly located on chronically sun-exposed areas such as the face, scalp, neck, and dorsum of the hands [3, 4] . The literature reports that the risk of progression of AK to invasive SCC (iSCC) varies between 0. 025% and 16% per year [5, 6] and about 40. 7% within 5 years incase of previous cutaneous SCC (cSCC) [5–7] . Lesion induration, bleeding, pain, and enlargement of the lesion in thickness and diameter suggest transforming AK into iSCC [8] . AK lesions are also accompanied by “field cancerization”, an area of tumorigenesis defined as an area of subclinical changes in the periphery of clinically visible AKs that display genetic changes similar to those found in AK lesions [9] . Since AK is a precancerous condition, it is important to implement treatment early enough to prevent cancer progression.  \nTreatment methods for actinic keratosis  \nThe treatment of AK should be individualized, taking into consideration patient safety, treatment efficacy, the number of AK lesions, comorbidities, patient preferences, and physician experience [10] . Primary prevention, including patient education, sun protection, and patient supervision, is essential in preventing AK and non-melanocytic skin cancers (NMSC) . AK treatment can be categorized as lesion-directed or field-directed. Lesion-directed treatments target individual AKs, while field-directed treatments address multiple, widespread, and subclinical AKs within “field cancerization” [3, 11] . Lesion-directed therapy is suitable for fewer than five AK lesions, mild to moderate photodamage, and a low risk of developing NMSC. Field-directed therapy is recommended for more than five AK lesions, severely UVdamaged skin, and a high risk of developing NMSC. Both approaches include topical treatments (imiquimod, 5-fluorouracil, diclofenac) and physical methods (cryotherapy, photodynamic therapy, chemical peels, laser therapy, electrocoagulation, curettage) .  \nSun protection  \nAll relevant existing guidelines, including those from the Polish Society of Dermatology (2014), the British Association of Dermatology (BAD, ","cbCaimrPtjs4Fx6b","https://ap.wps.com/l/cbCaimrPtjs4Fx6b","pdf",179945,11,"English","# Actinic keratosis: comprehensive review of current treatments and emerging therapeutic innovations\n## Introduction\n## Treatment methods for actinic keratosis\n## Lesion-directed versus field-directed approaches\n## Sun protection\n## Topical treatment methods\n## Imiquimod\n## 5-fluorouracil","[{\"question\":\"What is actinic keratosis and why is it clinically important?\",\"answer\":\"Actinic keratosis (AK) is a prevalent benign intraepidermal dysplasia, classified as squamous cell carcinoma in situ (SCC in situ). Because it is a precancerous condition, early treatment and prevention are important to reduce progression to invasive cancer.\"},{\"question\":\"What causes actinic keratosis and where does it typically occur?\",\"answer\":\"Chronic ultraviolet (UV) light exposure is the primary etiological factor. AK mainly develops on chronically sun-exposed body areas such as the face, scalp, neck, and the dorsum of the hands.\"},{\"question\":\"How are AK treatment strategies classified?\",\"answer\":\"AK treatment is categorized as lesion-directed or field-directed. Lesion-directed therapy targets individual lesions, while field-directed therapy addresses multiple widespread and subclinical lesions within field cancerization.\"}]","Actinic keratosis - comprehensive review of current treatments and emerging therapeutic innovations | PDF",1790146028,28,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/39297e3f024d558bddfd44e4b453c5f5.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e8d231efb6075011aa1e921eb5e9905.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ffcf88ca6fc73e43fcb1b04921f4faf5.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7473e41b71fe9c59ccf4691d44815c3.webp",980,1385]